FSD Pharma Inc. said it has informed Health Canada of its decision to forfeit the marijuana cultivation and sale licenses of its wholly-owned subsidiary, FV Pharma, Inc., and suspend all activities by FV Pharma within 30 days. Currently, FSD Pharma is in the process...

According to a recent study published in the journal Advances in Therapy, more and more patients are using cannabis for pain management as an alternative to opioids. Data from 2011 to 2015 showed positive cannabis-use trends among pain patients. Also, according to...

Sapphire Medical Foundation announced its first patient has secured medicine funding for one year. Two years following the rescheduling of cannabis-based medicinal products in the UK, Sapphire Medical has successfully proceeded through the grant-making processes that...

This report features a widespread study of the current market landscape in the cannabis industry and pharmaceuticals. The Study offers an informed opinion on the endocannabinoid system targeting drugs specifically and the like hood of adoption over the next decade....

Applied Cannabis Research announced that MedReleaf is planning to join the CA Clinics Observational study (CACOS) to explore the impact of medicinal cannabis on chronic pain in Veterans. The study is supported by MedReleaf Australia, which is committed to improving...

Research shows that cannabis can treat various kinds of chronic pain in patients. According to a recent study conducted by professors at the University of California, Irvine, and the University of California Cannabis could also be an effective treatment for chronic...